Close

IMGN Financial Facts

Loss from operations: -38.84M
Research and development: 32.91M
See Full Income Statement

Commitments and contingencies (Note E): 0
Accumulated deficit: -898.42M
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 4/25/24 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +73.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +51.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/4/16 Q416 -$0.51-$0.39 -$0.12$7.41M$17.11M N/A Details
2/17/17 Q217 -$0.39-$0.38 -$0.01$13.85M$18.1M = Details
10/28/16 Q117 -$0.51-$0.38 -$0.13$7.66M$21.12M = Details
1/29/16 Q216 -$0.38-$0.36 -$0.02N/A$17.87M N/A Details
10/27/15 Q116 -$0.39-$0.35 -$0.04$14.9M$15.84M N/A Details
7/31/15 Q415 -$0.71-$0.35 -$0.36$12.61M$15.42M N/A Details
5/5/17 Q117 -$0.20-$0.34 +$0.14$28.5M$16.16M = Details
8/2/19 Q219 -$0.29-$0.33 +$0.04$15.54M$9.48M = Details